07.02.12
Fullerton, CA-based Stauber Performance Ingredients, Inc., with New York, NY and Atlanta, GA-based equity sponsor, ICV Partners, has acquired Florida, NY-based Pharmline, Inc. from Gadot Biochemical Industries, Ltd.
“We are extremely pleased to join forces with Pharmline’s experienced management and product development team. For many years we have outsourced the majority of our manufacturing and processing, and while we will continue to do so for some of our business, the establishment of Pharmline as our manufacturing arm is a pivotal step to our future as we endeavor to become a complete ‘solution-provider’ to our growing customer base,” stated Dan Stauber, CEO of Stauber Performance Ingredients, Inc.
“We are extremely pleased to join forces with Pharmline’s experienced management and product development team. For many years we have outsourced the majority of our manufacturing and processing, and while we will continue to do so for some of our business, the establishment of Pharmline as our manufacturing arm is a pivotal step to our future as we endeavor to become a complete ‘solution-provider’ to our growing customer base,” stated Dan Stauber, CEO of Stauber Performance Ingredients, Inc.